Kevin O’Leary Predicts These 3 Psychedelic Companies Will Merge
2022年4月21日 · Famed investor Kevin O’Leary made a bold prediction last Tuesday, saying that psychedelic companies MindMed, atai Life Sciences and Compass Pathways will merge. For psychedelic stock investors, this would be a tsunami-sized event that would have ripple effects throughout the industry.
Mind Medicine: Why Kevin O'Leary Thinks This Psychedelics …
2021年1月6日 · Shark Tank star Kevin O'Leary has invested in hundreds of businesses over the years, some on-screen and some off. But few have attracted as much attention as his investment in psychedelic drug...
Kevin O’Leary: ‘Psychedelics Are My Highest Return This Year’
2020年10月23日 · Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Javier A. Muniz, M.D., as Vice President of Research and Development (R&D) Strategy.
What Happened to the Stock Backed by Mr. Wonderful?
2023年3月14日 · “I became a very early investor in MindMed (NEO: MMED, OTC: MNMD, FRA: MMQ), I became an advocate for the whole sector. It's the best investment I've made in decades. I think it's just the beginning of the game” says Kevin O’Leary. 2 years later, where is one of the leading companies at?
Kevin O'Leary Thinks MindMed, Compass Pathways & atai Will …
2022年4月30日 · Famed investor Kevin O’Leary made a bold prediction last Tuesday, saying that psychedelic companies MindMed, atai Life Sciences and Compass Pathways will merge. For psychedelic stock investors, this would be a tsunami-sized event that would have ripple effects throughout the industry.
Why Kevin O’Leary is betting on psychedelics
2020年3月6日 · Kevin O’Leary is backing a neuro-pharmaceutical company testing psychedelic-inspired medicines. As of this week the company, Mind Medicine (MindMed) Inc. is trading on the NEO Exchange. O’Leary told WP why he’s backing MindMed, citing the potential of its drugs to address problems like depression, alcoholism, and opioid addiction, issues ...
Kevin O'Leary-Backed MindMed Is 2nd Psychedelic Company to List On …
2021年4月26日 · MindMed will take its Kevin O'Leary-backed platform onto the Nasdaq Tuesday as only the 2nd psychedelic company to do so.
MINDMED Goes Public: An Interview with CEO J.R. Rahn and Investor Kevin ...
2020年4月23日 · Mind Medicine Inc. (MindMed), whose backers include entrepreneur Kevin O’Leary of “Shark Tank” fame, has become the first psychedelics pharmaceutical firm to go public.
MindMed Best In Psychedelic Space, Could Still Be In 'Third …
2021年3月21日 · Jason Raznick, the founder and CEO of Benzinga interviewed Kevin O’Leary on the “ Raz Report ” last week. Among the topics discussed was O’Leary’s stake in Mind Medicine Inc MMEDF. O’Leary on...
Shark Tank’s Kevin O’Leary Invests in Psychedelic Drug ... - Observer
2019年12月17日 · Shark Tank investor Kevin O’Leary was also part of an investment round of $6.2 million. Yes, something must be up—if MindMed got one of TV’s longest standing “sharks” to invest in the venture....
- 某些结果已被删除